Ovarian cancer survival remains poor despite recent advances in our understanding of genetic profiles. Unfortunately, the majority of ovarian cancer patients have recurrent disease after chemotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback